ICMR-Bharat Biotech Covid-19 vaccine trial results to be released by Aug 15

A total of 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered the topmost priority projects which are being monitored by the government

Bharat Biotech had recently received a nod for a clinical trial of its vaccine - Covaxin.

"This is the first indigenous vaccine being developed by India and is one of the top priority projects which is being monitored at the topmost level of the Government. The vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of virology. Pune- ICMR and BBIL are jointly working for the preclinical as well as clinical development of this vaccine," the letter written by ICMR DG Dr Bhargava read.

A total of 12 institutes have been asked by the ICMR to fast track clinical